99 related articles for article (PubMed ID: 9468585)
1. Plasma transforming growth factor beta levels in breast cancer patients.
Sminia P; Barten AD; van Waarde MA; Vujaskovic Z; van Tienhoven G
Oncol Rep; 1998; 5(2):485-8. PubMed ID: 9468585
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.
Kong FM; Anscher MS; Murase T; Abbott BD; Iglehart JD; Jirtle RL
Ann Surg; 1995 Aug; 222(2):155-62. PubMed ID: 7543740
[TBL] [Abstract][Full Text] [Related]
3. Preoperative transforming growth factor-beta 1 (TGF-beta 1) plasma levels in operable breast cancer patients.
Chod J; Zavadova E; Halaska MJ; Strnad P; Fucikova T; Rob L
Eur J Gynaecol Oncol; 2008; 29(6):613-6. PubMed ID: 19115689
[TBL] [Abstract][Full Text] [Related]
4. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
[TBL] [Abstract][Full Text] [Related]
6. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
[TBL] [Abstract][Full Text] [Related]
7. Conserving surgery - balance between good cosmetic aspect and local disease control in incipient breast cancer.
Gogescu G; Marinescu S; Brătucu E;
Chirurgia (Bucur); 2014; 109(4):461-70. PubMed ID: 25149608
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
[TBL] [Abstract][Full Text] [Related]
11. Vimentin expression in different types of breast carcinoma immunohistochemical study.
Essa TM; el Tatawi FA; Hamdi KN; Arafa WA
J Egypt Soc Parasitol; 1996 Aug; 26(2):433-42. PubMed ID: 8754651
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.
Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R
Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402
[No Abstract] [Full Text] [Related]
13. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
Silva J; García V; García JM; Peña C; Domínguez G; Díaz R; Lorenzo Y; Hurtado A; Sánchez A; Bonilla F
Breast Cancer Res; 2007; 9(4):R55. PubMed ID: 17711569
[TBL] [Abstract][Full Text] [Related]
14. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
15. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status.
Heer K; Kumar H; Read JR; Fox JN; Monson JR; Kerin MJ
Clin Cancer Res; 2001 Nov; 7(11):3491-4. PubMed ID: 11705867
[TBL] [Abstract][Full Text] [Related]
17. Patterns and determinants of surgical management of screen detected breast cancer in the South-East Netherlands.
Liebregts ME; van Riet YE; Nieuwenhuijzen GA; Rutten HJ; Duijm LE; Voogd AC
Breast; 2013 Oct; 22(5):713-7. PubMed ID: 23352567
[TBL] [Abstract][Full Text] [Related]
18. Clear margins for invasive lobular carcinoma: a surgical challenge.
Sakr RA; Poulet B; Kaufman GJ; Nos C; Clough KB
Eur J Surg Oncol; 2011 Apr; 37(4):350-6. PubMed ID: 21277728
[TBL] [Abstract][Full Text] [Related]
19. [Bilateral carcinoma of the breast].
Napolitano L; Grossi S; Cianchetti E
Ann Ital Chir; 1993; 64(6):665-8; discussion 668-9. PubMed ID: 8080156
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of breast carcinoma following immediate reconstruction: a 13-year review.
Noone RB; Frazier TG; Noone GC; Blanchet NP; Murphy JB; Rose D
Plast Reconstr Surg; 1994 Jan; 93(1):96-106; discussion 107-8. PubMed ID: 8278489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
